|
AGAP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.476840E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.355600E-02 |
| Normal-vs-Stage2 |
5.279800E-02 |
| Normal-vs-Stage3 |
2.022600E-04 |
| Normal-vs-Stage4 |
6.21349999999632E-05 |
| Stage1-vs-Stage2 |
3.697400E-03 |
| Stage1-vs-Stage3 |
8.18059999740939E-08 |
| Stage1-vs-Stage4 |
5.2209999990005E-08 |
| Stage2-vs-Stage3 |
4.654000E-01 |
| Stage2-vs-Stage4 |
2.336400E-01 |
| Stage3-vs-Stage4 |
5.281600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.032200E-02 |
| Normal-vs-AfricanAmerican |
6.961800E-01 |
| Normal-vs-Asian |
8.632800E-01 |
| Caucasian-vs-AfricanAmerican |
2.278400E-01 |
| Caucasian-vs-Asian |
5.464800E-01 |
| AfricanAmerican-vs-Asian |
9.916600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.040700E-03 |
| Normal-vs-Female |
4.586800E-01 |
| Male-vs-Female |
2.279500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.044200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.531000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.541900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.118000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.189000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.469000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.037200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.762800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.795000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.458400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.160580E-01 |
| Normal-vs-Grade 2 |
2.868200E-01 |
| Normal-vs-Grade 3 |
4.853700E-02 |
| Normal-vs-Grade 4 |
4.59890000525931E-08 |
| Grade 1-vs-Grade 2 |
2.802600E-01 |
| Grade 1-vs-Grade 3 |
2.682100E-02 |
| Grade 1-vs-Grade 4 |
1.75191999999269E-05 |
| Grade 2-vs-Grade 3 |
3.560000E-03 |
| Grade 2-vs-Grade 4 |
6.48879949771697E-10 |
| Grade 3-vs-Grade 4 |
1.993690E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.200100E-03 |
| Normal-vs-ccB subtype |
4.752800E-04 |
| ccA subtype-vs-ccB subtype |
3.8166000360107E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.290000E-02 |
| Normal-vs-N1 |
1.106620E-01 |
| N0-vs-N1 |
2.354000E-01 |
|
|
